Health Care & Life Sciences » Biotechnology | Prana Biotechnology Ltd.

Prana Biotechnology Ltd.

Prana Biotechnology Ltd.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$17.52 M
Shares Outstanding
533.89 M
Public Float
-
Prana Biotechnology Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.02
Market Cap
AUD23.63 M
Shares Outstanding
536.98 M
Public Float
518.37 M
Prana Biotechnology Ltd. ADR
Stock Exchange Frankfurt Stock Exchange
EPS
EUR0.71
Market Cap
EUR15.78 M
Shares Outstanding
8.95 M
Public Float
-
Prana Biotechnology Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$0.72
Market Cap
$16.76 M
Shares Outstanding
8.95 M
Public Float
-

Profile

Address
460 Bourke Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.pranabio.com
Updated 07/08/2019
Prana Biotechnology Ltd. engages in the development of therapy treatment for neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.

Financials

View All

Geoffrey Paul Kempler
Executive Chairman & Chief Executive Officer
Ira Shoulson
Independent Non-Executive Director